Your browser doesn't support javascript.
loading
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus.
Furie, Richard A; Bruce, Ian N; Dörner, Thomas; Leon, Manuel Gustavo; Leszczynski, Piotr; Urowitz, Murray; Haier, Birgit; Jimenez, Teri; Brittain, Claire; Liu, Jiajun; Barbey, Catherine; Stach, Christian.
  • Furie RA; Northwell Health, Great Neck, NY, USA.
  • Bruce IN; NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Trust.
  • Dörner T; Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Leon MG; Charité Berlin, Berlin, Germany.
  • Leszczynski P; Investigaciones Clínicas, Lima, Peru.
  • Urowitz M; Poznan University of Medical Sciences, Poznan, Poland.
  • Haier B; Toronto Western Hospital, Toronto, Ontario, Canada.
  • Jimenez T; UCB Pharma, Monheim am Rhein, Germany.
  • Brittain C; UCB Pharma, Raleigh, NC, USA.
  • Liu J; UCB Pharma, Slough, UK.
  • Barbey C; Biogen, Cambridge, MA, USA.
  • Stach C; Biogen, Baar, Switzerland.
Rheumatology (Oxford) ; 60(11): 5397-5407, 2021 11 03.
Article en En | MEDLINE | ID: mdl-33956056
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Fragmentos Fab de Inmunoglobulinas / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Polietilenglicoles / Fragmentos Fab de Inmunoglobulinas / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article